Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.54 |
| ▸ | FNTB | P49356 | 3/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16079890 | 1.00 | FNTA (0.54) | FNTAFNTBPGGT1BKMT2AGGPS1 | |
| SCHEMBL16079903 | 0.87 | FNTA (0.54) | FNTAFNTBKMT2A | |
| SCHEMBL16079884 | 0.87 | FNTA (0.54) | FNTAFNTBKMT2A | |
| SCHEMBL16079885 | 0.81 | FNTA (0.59) | FNTAFNTBPGGT1BKMT2AGGPS1 | |
| SCHEMBL16079897 | 0.81 | FNTA (0.59) | FNTAFNTBPGGT1BKMT2AGGPS1 | |
| SCHEMBL16079883 | 0.81 | FNTA (0.51) | FNTAFNTBPGGT1B | |
| SCHEMBL16079901 | 0.81 | FNTA (0.51) | FNTAFNTBPGGT1B | |
| SCHEMBL9417691 | 0.79 | KMT2A (0.48) | KMT2AGGPS1 | |
| SCHEMBL31217469 | 0.78 | ALOX15 (0.43) | FNTAPGGT1BGGPS1 | |
| SCHEMBL8390164 | 0.77 | FNTA (0.50) | FNTAPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150258039-A1 | PREPARATION OF GGA AND DERIVATIVES THEREOF AND THEIR CO-CRYSTALLIZATION WITH UREA OR THIOUREA | COYOTE PHARMACEUTICALS, INC. (US) | 2015-09-17 | — | — | US | disclosed |
| US-20140274967-A1 | Polyisoprenyl derivatives and uses thereof | COYOTE PHARMACEUTICALS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140274967-A1 | Polyisoprenyl derivatives and uses thereof | PHOSPHO1, GGPS1, PPIP5K2 | FNTA 5/4885FNTB 64/4885PGGT1B 63/4885 |
| US-20150258039-A1 | PREPARATION OF GGA AND DERIVATIVES THEREOF AND THEIR CO-CRYSTALLIZATION WITH UREA OR THIOUREA | UGP2, TGM2, GGCT | FNTA 316/4885FNTB 800/4885PGGT1B 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.